B E Journal of Economic Analysis & Policy, published by Walter de Gruyter GmbH in Germany, stands as a pivotal resource in the field of economics and econometrics since its establishment in 2001. Boasting an ISSN of 2194-6108 and an E-ISSN of 1935-1682, this journal is committed to advancing the understanding of economic policies and their analysis through rigorous, peer-reviewed research. With an impressive categorization that includes a Q2 ranking in the Economics, Econometrics and Finance (miscellaneous) category and a Q3 ranking in other economics niches as of 2023, it emphasizes the importance of empirical research and robust theoretical frameworks. The journal is indexed in Scopus, reaffirming its credibility, with ranks in the 49th and 32nd percentiles for its respective categories. Researchers, professionals, and students alike will find valuable insights and innovative perspectives within its pages, as it continues to shape discussions around economic policy in an ever-evolving global landscape.

ClinicoEconomics and Outcomes Research is a prestigious open-access journal published by DOVE MEDICAL PRESS LTD, located in New Zealand. Since its inception in 2009, it has established itself as a vital resource for researchers and practitioners in the fields of economics, health policy, and outcomes research. With a commendable impact reflected in its rankings—Q1 in Economics, Econometrics and Finance and Q2 in Health Policy—the journal effectively bridges the gap between economic evaluation and healthcare delivery. This publication is particularly significant for those focused on the economic implications of health interventions, policy analysis, and decision-making processes in healthcare systems. As an open-access journal, ClinicoEconomics and Outcomes Research ensures that its valuable content is widely accessible, enhancing knowledge dissemination and fostering collaboration among academia, industry, and policymakers. With an ambition to contribute to the improvement of health outcomes through rigorous research, it invites submissions that address the multifaceted challenges facing the economics of healthcare today. Join the scholarly dialogue where innovative ideas in health economics thrive!

INTERNATIONAL JOURNAL OF HEALTH PLANNING AND MANAGEMENT is an esteemed publication within the fields of Health Policy and Medicine, published by WILEY, a renowned academic publisher based in the United Kingdom. Since its inception in 1985, this journal has been at the forefront of advancing knowledge and practice in health planning and management, drawing on a diverse range of empirical and theoretical research to inform policy and improve health outcomes. With an impressive impact factor and ranked in the top quartile for both health policy and miscellaneous medicine, the journal is committed to publishing high-quality research that meets the needs of practitioners, policymakers, and scholars alike. Currently, it operates without open access, ensuring that all published articles maintain a rigorous standard of peer review while providing an essential platform for dialogue among professionals in the field. The INTERNATIONAL JOURNAL OF HEALTH PLANNING AND MANAGEMENT continues to play a vital role in shaping health systems and policies, making it an indispensable resource for anyone involved in health research and management.

Health Economics Policy and Law is a premier journal published by Cambridge University Press that focuses on the intersection of health economics, policy formulation, and legal frameworks. Since its establishment in 2006, the journal has been at the forefront of disseminating high-quality research, covering critical issues in the ever-evolving health policy landscape. With an impressive impact factor and ranked in the Q1 category of Health Policy according to the latest metrics (2023), it serves as a vital resource for academic researchers, professionals, and students alike. The journal aims to stimulate discussion and influence decision-making by providing rigorous empirical studies, policy analyses, and theoretical evaluations. While not open access, its publications are accessible through institutional subscriptions, reflecting its commitment to supporting scholarly discourse within the field. As it continues to converge towards its 2024 goals, Health Economics Policy and Law remains an essential platform for advancing knowledge and fostering innovation in health policy and law.

Journal of the Economics of Ageing, published by ELSEVIER, is a leading international journal dedicated to exploring the economic aspects of ageing in the global context. With an ISSN of 2212-828X, it aims to provide a platform for innovative research that addresses the socio-economic implications of demographic shifts, particularly those related to life-span and life-course studies. Since its inception in 2013, the journal has rapidly established itself within the Q2 category in both the Economics and Econometrics and Life-span and Life-course Studies fields, reflecting its significant contribution to these disciplines. Based in the Netherlands, this journal is indexed with a respectable percentile ranking, such as 69th in Life-span and Life-course Studies, confirming its value to researchers and professionals alike. Committed to disseminating impactful research, the Journal of the Economics of Ageing ultimately seeks to influence policy and funding decisions that shape the future of ageing populations.

International Journal of Health Economics and Management is a premier academic journal published by SPRINGER, focusing on innovative research at the intersection of health economics and management practices. Established in 2015, this journal caters to a diverse range of disciplines, integrating rigorous economic analysis with vital health policy discussions. With an impressive impact factor reflective of its influential publications, it holds a distinguished Q1 ranking in Economics, Econometrics, and Finance, and a Q2 ranking in Health Policy for 2023. The journal provides an open access model, enabling wider dissemination of research findings to academics, policymakers, and healthcare professionals globally. Researchers and students alike will find this journal invaluable for its commitment to advancing knowledge in health economics and improving healthcare management practices through empirical studies and theoretical insights. For more information, or to access articles, please refer to the journal's platform.

REVUE ECONOMIQUE, published by PRESSES FOND NAT SCI POLIT in France, is a distinguished academic journal with an ISSN of 0035-2764 and an E-ISSN of 1950-6694. Established in 1974, the journal has evolved significantly over the years, focusing on a diverse range of topics within the field of economics, econometrics, and finance. With its commitment to presenting in-depth research and innovative perspectives, REVUE ECONOMIQUE serves as a vital resource for scholars, professionals, and students seeking to enhance their understanding of economic theories and practices. Although it is currently categorized in the Q4 quartile, ranking 241 out of 288 in the field, the journal aims to foster new dialogues and disseminate valuable insights that contribute to the economic discourse. The journal is not available as open access, but its rich repository of articles continues to attract readers interested in the complexities of economic dynamics. For more information, you can refer to their address at 27 RUE SAINT-GUILLAUME, 75341 PARIS 07, FRANCE.

ECONOMIC POLICY is a leading academic journal published by Oxford University Press, focusing on a broad spectrum of topics within the field of economics and related disciplines. With its ISSN 0266-4658 and E-ISSN 1468-0327, the journal serves as a vital platform for disseminating cutting-edge research and innovative policy analysis critical to both scholars and practitioners. As a testament to its quality and significance, ECONOMIC POLICY is classified in the Q1 quartile for both Economics and Econometrics and Management, Monitoring, Policy, and Law, and boasts impressive rankings within Scopus—placing it in the top 25% of its respective fields. Operating from the esteemed Oxford campus in the United Kingdom, the journal has produced a wealth of knowledge since its inception in 1988, with plans to continue shaping economic discourse through 2024 and beyond. While the journal does not offer Open Access options, it remains a cornerstone for anyone dedicated to understanding the complexities of economic policy and its impact on global society.

The Journal of Demographic Economics, published by Cambridge University Press, stands as a leading interdisciplinary platform dedicated to the exploration and advancement of research in the intertwined fields of demography, economics, and geography. With an impact factor that reflects its esteemed position—ranking in the Q1 quartile for Demography (2023)—the journal fosters scholarly dialogue through high-quality articles that elucidate the complex interactions between population dynamics and economic trends. Operating under an open access model, the journal ensures that its findings are widely accessible, promoting inclusivity and engagement among researchers, professionals, and students alike. The Journal of Demographic Economics endeavors to bridge gaps in knowledge by publishing innovative and rigorous studies, thereby contributing significantly to both theoretical frameworks and practical applications across various domains. Drawing submissions from a global audience, this journal not only enhances the understanding of demographic transitions but also informs policy decisions and socioeconomic development strategies, making it an essential resource for those invested in demographic and economic research.

Expert Review of Pharmacoeconomics & Outcomes Research is a leading journal published by TAYLOR & FRANCIS LTD, focusing on the critical intersection of pharmacoeconomics and healthcare outcomes. Established in 2001, the journal has been a key resource for researchers and professionals in the fields of health policy, medicine, and pharmacology, consistently ranked in the top quartile of these categories for its influential insights. With an ISSN of 1473-7167 and an E-ISSN of 1744-8379, it delivers cutting-edge research that informs healthcare decisions and policy frameworks. The journal's rigorous peer-review process ensures the publication of high-quality, impactful articles that address contemporary challenges and advancements in pharmacoeconomic evaluations. As of 2023, it boasts a commendable ranking of #106 in Health Policy and #124 in Pharmacology, affirming its relevance and contribution to the field. Despite being a subscription-based journal, the strength of its content makes it an invaluable tool for researchers and practitioners aiming to enhance patient outcomes and optimize resource allocation in healthcare systems.